Stephen Jay Kanes
Inventor
Stats
- 0 US patents issued
- 25 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 25 US Applications Filed
- 49 Total Citation Count
- Aug 24, 2023 Most Recent Filing
- Aug 21, 2013 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SAGE THERAPEUTICS, INC. | 1
1 | 2013
2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| Brynlawn, PA, US | Apr 16, 20 - Sep 10, 24 |
| Swarthmore, PA, US | Feb 27, 14 - Dec 14, 23 |
| Swathmore, PA, US | Jul 25, 24 - Jul 25, 24 |
| Villanova, PA, US | Oct 13, 22 - Jul 04, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 22 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 18 |
| C07D: | HETEROCYCLIC COMPOUNDS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12083131 | 2024 | Neuroactive steroids, compositions, and uses thereof | 0 |
| 2024/0245,711 | 2024 | A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER | 0 |
| 2024/0216,395 | 2024 | 19-NOR C3,3-DISUBSTITUTED C21 -N-PYRAZOLYL STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION | 0 |
| 2024/0216,396 | 2024 | NEUROACTIVE STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION IN A LACTATING FEMALE | 0 |
| 2023/0414,636 | 2023 | USE OF GABAA MODULATORS FOR TREATMENT OF RESPIRATORY CONDITIONS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.